Erratum (DOI:10.1016/j.hrthm.2008.12.032);Free radical scavenger specifically prevents ischemic focal ventricular tachycardia

Heart Rhythm

Volumn 6, Issue 4, 2009, Pages 530-536

  Xing, Dezhi ^a   Chaudhary, Ashok K ^a   Miller Jr , Francis J ^a   Martins, James B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Focal ventricular tachycardia; Scavenging of reactive oxygen species; TEMPO; Triggered activity

Indexed keywords

2,2,6,6 N OXYLTETRAMETHYLPIPERIDINE; ETHIDIUM; LUCIGENIN; PIPERIDINE DERIVATIVE; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; ENDOCARDIUM; EXPERIMENTAL DOG; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART PROTECTION; HEART VENTRICLE TACHYCARDIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; STAINING; THERAPY EFFECT; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 62549104205     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.09.027     Document Type: Erratum

References (27)

1. Xing D., and Martins J.B. Triggered activity due to delayed afterdepolarizations in sites of focal origin of ischemic ventricular tachycardia. Am J Physiol Heart Circ Physiol 287 (2004) H2078-H2084
2. Xing D., Murry D.J., Schmidt M.S., et al. Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity. Heart Rhythm 4 (2007) 629-637
3. Gelvan D., Saltman P., and Powell S.R. Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci 88 (1991) 4680-4684
4. Beresewicz A., and Horackova M. Alterations in electrical contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms. J Mol Cell Cardiol 23 (1991) 899-918
5. Das D.K., and Engelman R.M. Oxygen radicals: systemic events and disease processes. In: Das D.K., and Essman W.B. (Eds). Oxygen Free Radicals (1990), Karger, Basel 97-128
6. Pasdois P., Beauvoit B., Tariosse L., et al. Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff perfused rat hearts using optic fibers. Am J Physiol Heart Circ Physiol 294 (2008) H2088-H2097
7. Duilio C., Ambrosio G., Kuppusamy P., et al. Neutrophils are primary source of O2 radical during reperfusion after prolonged myocardial ischemia. Am J Physiol 280 (2001) H2649-H2657
8. Guo R., Gao X., Wang W., et al. Tempol reduces reperfusion-induced arrhythmias in anesthetized rats. Pharmacol Res 52 (2005) 192-198
9. Hicks J.J., Montes-Cortes D.H., Cruz-Dominguez M.P., et al. Antioxidants decrease reperfusion induced arrhythmias in myocardial infarction with ST-elevation. Front Bioscience 12 (2007) 2029-2037
10. Hahn S.M., and Mitchell S.E. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage. Free Radic Biol Med 23 (1997) 879-884
11. Kato N., Yanaka K., Hyodo K., et al. Stable nitroxide tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia. Brain Res 979 (2003) 188-193
12. Rak R., Chao D.L., Pluta R.M., et al. Neuroprotection by the stable nitroxide tempol during reperfusion in a rat model of transient focal ischemia. J Neurosurg 92 (2000) 646-651
13. Sepodes B., Maio R., Pinto R., et al. Tempol, an intracellular free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant Proc 36 (2004) 849-853
14. McDonald M.C., Zacharowski K., Bowes J., et al. Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic Biol Med 27 (1999) 493-503
15. Miller Jr. F.J., Gutterman D.D., Rios C.D., et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82 (1998) 1298-1305
16. Miller Jr. F.J., Sharp W.J., Fang X., et al. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 22 (2002) 560-565
17. Li L., Jin Q., Huang J., et al. Intramural foci during long duration fibrillation in the pig ventricle. Circ Res 102 (2008) 1256-1264
18. Zhang G., Kimura S., Nishiyama A., et al. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65 (2005) 230-238
19. Mitchell J.B., Samuni A., Krishna M.C., et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29 (1990) 2802-2807
20. Hahn S.M., DeLuca A.M., Coffin D., et al. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int J Radiat Oncol Biol Phys 42 (1998) 839-842
21. Agnes H., Nagy L., Parratt J., et al. N-2-mercaptopropionylglycine, a scavenger of reactive oxygen species, does not modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs. Cardiovasc Drugs Ther 18 (2004) 449-459
22. Xu H., Fink G.D., Chen A., Watts S., et al. Nitro oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol 281 (2001) 975-980
23. Kabell G., Brachmann J., Scherlag B.J., et al. Mechanisms of ventricular arrhythmias follow one stage and two stage coronary reperfusion: evidence for both reentry and enhanced automaticity. J Electrocardiol 18 (1985) 87-96
24. Arnar D.O., Xing D.Z., Lee H., et al. Prevention of ischemic ventricular tachycardia of Purkinje origin: a role for α2 adrenoceptors in Purkinje?. Am J Physiol 287 (2001) H1182-H1190
25. Zima A.V., and Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 71 (2006) 310-321
26. Song Y., Shryock J.C., Wagner S., et al. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318 (2006) 214-222
27. Hool L.C. Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: mechanism for mediating pathology. Clin Exp Pharmacol Physiol 35 (2008) 229-234